Immunocore Wins Prix Galien UK Award for KIMMTRAK

Immunocore Wins Prix Galien UK Award for KIMMTRAK

Immunocore has been awarded a Prix Galien UK award for KIMMTRAK, its treatment for metastatic uveal melanoma- a rare and aggressive form of eye cancer. The Prix Galien UK is one of the highest accolades in the life sciences sector, recognising outstanding innovation...
Loading...